Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) Director Michael G. Grey sold 14,608 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The shares were sold at an average price of $28.00, for a total value of $409,024.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […]
Mirum Pharmaceuticals (NASDAQ:MIRM – Get Rating) had its target price trimmed by Raymond James from $83.00 to $81.00 in a research report sent to investors on Thursday morning, The Fly reports. Several other analysts also recently commented on the stock. HC Wainwright reissued a buy rating and set a $61.00 price objective on shares of […]
Los Angeles Capital Management LLC acquired a new position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 29,620 shares of the company’s stock, valued at approximately $576,000. A […]